Management Change16 Jun 2026, 04:13 pm
Gland Pharma Director Resigns Due to Potential Conflict of Interest
AI Summary
Gland Pharma Ltd announced the resignation of its Independent Director, Mr. Satyanarayana Murthy Chavali, effective June 15, 2026. The resignation stems from a potential conflict of interest, as Mr. Chavali is a promoter and director of another company planning to enter a business segment that may overlap with Gland Pharma's proposed activities. The company has provided the necessary disclosures as per SEBI LODR Regulations, 2015.
Key Highlights
- Independent Director Satyanarayana Murthy Chavali has resigned.
- Resignation is due to potential future conflict of interest.
- Another company Mr. Chavali is involved with may enter a similar business segment.
- The resignation is effective from June 15, 2026.
Price Impact
More from GLAND